Implantable Device for Administering a Therapeutic Agent
Summary
USPTO published patent application US20260096984A1 filed by inventors Harsh Patel and Jeffrey Haley on October 3, 2025. The application covers an implantable device for delivering therapeutic agents, featuring a core polymer matrix with hydrophobic poly ortho ester (POE) polymer having a glass transition temperature between -20°C and 40°C. The device is designed for controlled therapeutic agent release in vivo.
What changed
USPTO published patent application US20260096984A1 for an implantable therapeutic delivery device. The application claims an implantable device comprising a core polymer matrix with a hydrophobic first poly ortho ester (POE) polymer having a Tg between approximately -20°C and 40°C, with one or more dispersed therapeutic agents. The device is intended for controlled release of therapeutic agents in vivo.
For affected parties, this publication establishes prior art as of the October 3, 2025 filing date. Competitors developing similar implantable drug delivery systems should review the claims for potential infringement risks. Medical device manufacturers and pharmaceutical companies working on polymer-based delivery systems may need to conduct freedom-to-operate analyses.
What to do next
- Monitor patent prosecution for examiner actions
- Evaluate patent claims for freedom-to-operate analysis
- Assess device development timeline relative to patent expiry
Archived snapshot
Apr 13, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Implantable Device for Administering a Therapeutic Agent
Application US20260096984A1 Kind: A1 Apr 09, 2026
Inventors
Harsh Patel, Jeffrey Haley
Abstract
An implantable device for the delivery of a therapeutic agent is provided. The implantable device includes a core having a core polymer matrix within which is dispersed one or more therapeutic agents. The core polymer matrix includes a hydrophobic polymer comprising a first poly ortho ester (POE) polymer. The first POE polymer has a Tg of between about −20° C. and 40° C. as determined in accordance with ASTM E1640-18. Methods for forming the implantable device are also provided.
CPC Classifications
A61K 9/0024 A61K 31/4439 A61K 47/10 C07K 16/32
Filing Date
2025-10-03
Application No.
19348846
Related changes
Get daily alerts for USPTO Patent Applications - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.